Score Overview
See the full market ranking โ
Zymeworks Inc. Common Stock fundamental performance
Between 2020 and 2025, revenue grew from $ 38M to $ 105M and net income went from -$ 180M to -$ 81M. Revenue increased in 3 of those 5 years; net income in 2.
Across Zymeworks Inc. Common Stock's full reported history, from 2017 to 2025, revenue grew from $ 51M to $ 105M and net income went from -$ 10M to -$ 81M. Revenue increased in 56% of the years measured; net income in 22%.
Zymeworks Inc. Common Stock currently holds a 5-year HDB Score of 4.6 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 24.93 | โ |
1 Year2025-08-12 | $ 13.02 | 91.47% |
5 Years2021-08-12 | $ 31.09 | -19.81% |
All Time2017-04-28 | $ 13.00 | 91.77% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2017-04-28 |
|---|---|---|---|---|
| Price | $ 24.93 | $ 13.02 | $ 31.09 | $ 13.00 |
| Return | โ | 91.47% | -19.81% | 91.77% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 37M | -$ 149M | $ 270.69B |
| 2025 | $ 105M | -$ 81M | $ 228M |
| 2024 | $ 76M | -$ 122M | $ 225M |
| 2023 | $ 76M | -$ 118M | $ 374M |
| 2022 | $ 412M | $ 124M | $ 492M |
| 2021 | $ 26M | -$ 211M | $ 252M |
| 2020 | $ 38M | -$ 180M | $ 426M |
| 2019 | $ 29M | -$ 145M | $ 298M |
| 2018 | $ 53M | -$ 36M | $ 200M |
| IPO2017 | $ 51M | -$ 10M | $ 87M |
Explore beyond ZYME
You're looking at Zymeworks Inc. Common Stock. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
